Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa	Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder	Recruiting	Not stated	2025-08-07		NCT07109765

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking Union Medical College	33

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No. 1 Shuai Fu Yuan, Dongcheng District, Beijing	Beijing	China	2

Clinical trials